Source:WebMD
Date: February 27, 2006
Summary:
Stem cell transplants may provide benefits in treating Huntington's disease, according to a new study. Researchers found the benefits of experimental stem cell therapy in reducing symptoms -- such as muscle stiffness and memory loss -- peaked after two years and then faded four to six years after the procedure in people with Huntington's disease.
Monday, February 27, 2006
Thursday, February 23, 2006
Stem Cells Might Fight Circulatory Disorder Peripheral artery disease can lead to leg ulcers, amputation
Source: HealthDay News
Date: February 23, 2006
Summary:
Stem cell injections might someday be used to treat a debilitating cardiovascular condition called peripheral arterial disease (PAD), researchers say.
Date: February 23, 2006
Summary:
Stem cell injections might someday be used to treat a debilitating cardiovascular condition called peripheral arterial disease (PAD), researchers say.
Thursday, February 16, 2006
Johns Hopkins Scientists Map Brain Area That May Aid Hunt For Human Brain Stem Cells
Source: Johns Hopkins Medical Institutions
Posted: February 16, 2006
Summary:
A study led by a Johns Hopkins neurosurgeon has provided the first comprehensive map of a part of the adult human brain containing astrocytes, cells known to produce growth factors critical to the regeneration of damaged neural tissue and that potentially serve as brain stem cells.
Posted: February 16, 2006
Summary:
A study led by a Johns Hopkins neurosurgeon has provided the first comprehensive map of a part of the adult human brain containing astrocytes, cells known to produce growth factors critical to the regeneration of damaged neural tissue and that potentially serve as brain stem cells.
Tuesday, February 14, 2006
Rebuilding a damaged heart
Source: The Washington Times
Date: February 14, 2006
Summary:
Rsearchers at the Johns Hopkins University School of Medicine and its Heart Institute in Baltimore are hoping that dying hearts can be made new. Because of recent research, many doctors believe the heart has regenerative capacity. The study's lead researcher has been enrolling heart attack patients in a trial to see if mesenchymal stem cells from bone marrow can regenerate a damaged heart. He previously performed trials with pig hearts.
Date: February 14, 2006
Summary:
Rsearchers at the Johns Hopkins University School of Medicine and its Heart Institute in Baltimore are hoping that dying hearts can be made new. Because of recent research, many doctors believe the heart has regenerative capacity. The study's lead researcher has been enrolling heart attack patients in a trial to see if mesenchymal stem cells from bone marrow can regenerate a damaged heart. He previously performed trials with pig hearts.
Tuesday, February 07, 2006
Stem Cell Breakthrough Helps 85% Of Type 2 Diabetes Patients
Source: Foundation Don Roberto Fernández Viña via Medical News Today
Date: 07 Feb 2006
Summary:
A study carried out in Argentina by a team of researchers from a Not-For-Profit Organization called ‘Don Roberto Fernandez Viña Foundation' (San Nicolas- Buenos Aires, Argentina) demonstrated that stem cells implanted into type 2 diabetes patients, in direct form into the pancreas, improve the production of Endogenous Insulin, increase the levels of “C Peptide”, decrease blood glucose levels and glycated hemoglobin levels faster than other treatments. 84% of the patients that had received the autologuous bone marrow cells could also abandon the drugs that stimulate insulin production or the insulin that they had been receiving previously. There were no complications at all, demonstrating the safety of the technique, since the extraction, the cellular implants and evolution of the patients. The most likely reason of this improvement is that the implanted autologuous stem cells regenerate the destroyed Beta Cells in the Islets of Langherhams in the pancreas of diabetes patients. It is also possible that they originate new Beta cells which produce the new Insulin.
Date: 07 Feb 2006
Summary:
A study carried out in Argentina by a team of researchers from a Not-For-Profit Organization called ‘Don Roberto Fernandez Viña Foundation' (San Nicolas- Buenos Aires, Argentina) demonstrated that stem cells implanted into type 2 diabetes patients, in direct form into the pancreas, improve the production of Endogenous Insulin, increase the levels of “C Peptide”, decrease blood glucose levels and glycated hemoglobin levels faster than other treatments. 84% of the patients that had received the autologuous bone marrow cells could also abandon the drugs that stimulate insulin production or the insulin that they had been receiving previously. There were no complications at all, demonstrating the safety of the technique, since the extraction, the cellular implants and evolution of the patients. The most likely reason of this improvement is that the implanted autologuous stem cells regenerate the destroyed Beta Cells in the Islets of Langherhams in the pancreas of diabetes patients. It is also possible that they originate new Beta cells which produce the new Insulin.
Friday, February 03, 2006
Life-threatening Lupus Responds To Stem Cell Transplant Therapy
Source: Northwestern Memorial Hospital
Posted: February 3, 2006
Summary:
Transplanting patients with blood stem cells that originate from their own bone marrow can induce the remission of life-threatening, treatment-resistant lupus, according to a study that took place at Northwestern Memorial Hospital in Chicago. Researchers found that 50 percent of the 50 patients in the study had disease-free survival at five years with an overall five-year survival rate of 84 percent. The study is published in the February 1 issue of the Journal of the American Medical Association.
Posted: February 3, 2006
Summary:
Transplanting patients with blood stem cells that originate from their own bone marrow can induce the remission of life-threatening, treatment-resistant lupus, according to a study that took place at Northwestern Memorial Hospital in Chicago. Researchers found that 50 percent of the 50 patients in the study had disease-free survival at five years with an overall five-year survival rate of 84 percent. The study is published in the February 1 issue of the Journal of the American Medical Association.
Subscribe to:
Posts (Atom)